2020
DOI: 10.1016/j.brainresbull.2019.11.018
|View full text |Cite
|
Sign up to set email alerts
|

TRPM2 ion channel is involved in the aggravation of cognitive impairment and down regulation of epilepsy threshold in pentylenetetrazole-induced kindling mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
10
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(10 citation statements)
references
References 49 publications
0
10
0
Order By: Relevance
“…Additionally, TRPM2 KO markedly improves neurological outcomes such as learning and memory following transient focal or global ischemic insult (Perraud et al, 2001;Ye et al, 2014), further indicating a critical role for TRPM2-assocated delayed neuronal death in cognitive dysfunction. Recently, pharmacological inhibition of TRPM2 channels was shown to obviously attenuate cognitive deficits in rodent models of diabetes (Thapak et al, 2020), global ischemia (Dietz et al, 2020), chronic cerebral hypoperfusion (Miyanohara et al, 2018), aging (Kakae et al, 2019), epilepsy (Zheng et al, 2020) and AD . Based on these novel findings, it was hypothesized that TRPM2 could be targeted in a therapeutic strategy for alleviating brain injury and cognitive impairment associated with the above conditions.…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, TRPM2 KO markedly improves neurological outcomes such as learning and memory following transient focal or global ischemic insult (Perraud et al, 2001;Ye et al, 2014), further indicating a critical role for TRPM2-assocated delayed neuronal death in cognitive dysfunction. Recently, pharmacological inhibition of TRPM2 channels was shown to obviously attenuate cognitive deficits in rodent models of diabetes (Thapak et al, 2020), global ischemia (Dietz et al, 2020), chronic cerebral hypoperfusion (Miyanohara et al, 2018), aging (Kakae et al, 2019), epilepsy (Zheng et al, 2020) and AD . Based on these novel findings, it was hypothesized that TRPM2 could be targeted in a therapeutic strategy for alleviating brain injury and cognitive impairment associated with the above conditions.…”
Section: Discussionmentioning
confidence: 99%
“…The TRPM2 channel is widely distributed throughout the body and is highly sensitive to activation by OS-inducing stimuli [ [31] , [32] , [33] ]. A large number of studies have been carried out over the past decades that provide compelling evidence to show that the TRPM2 channel is a key mechanism mediating OS-induced alteration in intracellular Ca 2+ and Zn 2+ homeostasis to disrupt various cellular functions and further support a significant role for aberrant TRPM2 channel activity in diverse OS-associated pathologies [ [34] , [35] , [36] , [37] , [38] , [39] , [40] , [41] , [42] , [43] , [44] , [45] , [46] , [47] , [48] ]. A well-established mechanism, among others, by which the TRPM2 channel contributes to these pathological processes, is to mediate OS-induced cell death.…”
Section: Introductionmentioning
confidence: 99%
“…19 The neuroprotective effect of TRPM2 knockout could decrease neuronal apoptosis via PARP-1/BNIP3/AIF in epilepsy. 36 KIF4 mutations increased the affinity of binding with PARP1 and contributed to epilepsy susceptibility. 37 In this study, SV2A protected mitochondria, inhibiting the translocation of AIF to the nucleus, subsequently inhibiting parthanatos, and ultimately protecting DNA from degradation.…”
Section: Discussionmentioning
confidence: 99%
“… 19 The neuroprotective effect of TRPM2 knockout could decrease neuronal apoptosis via PARP‐1/BNIP3/AIF in epilepsy. 36 KIF4 mutations increased the affinity of binding with PARP1 and contributed to epilepsy susceptibility. 37…”
Section: Discussionmentioning
confidence: 99%